Disintegration time

Testing of disintegration behaviour of tablets, dragees or capsules in the frame of galenic, release and stability testing

Therapeutic Modalities:

Small Molecules

Development Phases:

Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

Harmonized EP 2.9.1 and USP <701> and JP